Training- and Cost-effectiveness of an Internet-based Lifestyle-integrated Functional Exercise Program (iLiFE)
Launched by CHINESE UNIVERSITY OF HONG KONG · Jan 12, 2023
Trial Information
Current as of May 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
All subjects will then be randomly assigned to receive either an internet-based therapist-led LiFE program with a home environment safety assessment (iLiFE) or attention control intervention. Randomization into block groups of four in a 1:1 ratio (the iLiFE group or the attention control group) will be generated in a password-protected excel file by independent research personnel not involved in data collection or intervention after the baseline assessment. The randomization will be concealed by the independent personnel. Research assistants who are blinded to the group allocation will cond...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • aged ≥ 65 years,
- • community-dwelling,
- • have a fall history in the previous 12 months,
- • have a moderate or above risk of falls as assessed by the Physiological Profile Assessment (total z-score ≥ 1)
- • can ambulate on level surfaces without physical contact of another person as assessed by Functional Ambulation Category (score ≥ 3)
- • cognitively intact as assessed by the Hong Kong version of the Montreal Cognitive Assessment-5-minute protocol (score ≥ 16th percentile of the age and education-adjusted cut-off score)
- • able to communicate effectively.
- Exclusion Criteria:
- • uncorrected vision or hearing impairment,
- • unstable medical condition that may preclude the planned exercises, and
- • have been receiving or planning to receive any fall prevention program within the study period.
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Timothy Kwok
Principal Investigator
The Chinese Univsersity of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials